Thermo Fisher Scientific's third-quarter profit declined and revenue missed estimates as its two biggest divisions struggled.

Mutual Advisors LLC lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 10.9% in the 3rd quarter, according to its most recent Form 13F filing with the ...

Thermo Fisher boosted the lower end of its forecast for adjusted 2024 earnings, now anticipating net profit in a range between $21.35 and $22.07 a share, compared with the prior target of ...

Thermo Fisher Scientific Inc.'s Q3 results demonstrated some end-market stability, particularly in the life science market.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Thermo Fisher Scientific (TMO) stock falls as the company disappoints with Q3 revenue miss but reaffirms 2024 outlook. Read ...

Thermo Fisher Scientific's Q3 revenue of $10.59 billion missed expectations. Adjusted EPS beat estimates but dropped ...

A workstation in a research lab stocked with laboratory products and services. Thermo Fisher Scientific Inc. (NYSE:TMO), a ...

Analysts expect Thermo Fisher Scientific to report an earnings per share (EPS) of $5.25. The market awaits Thermo Fisher Scientific's announcement, with hopes high for news of surpassing estimates and ...

Amid flat Q3 revenue, Thermo Fisher tightens earnings guidance and doubles down on innovation to fuel future growth ...

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Kontra Investment Xchange’s Substack by Kontra. In ...

Thermo Fisher Scientific posted a modest decline in third-quarter net income, but boosted the lower end of its projected range for 2024 operating earnings on steady sales of laboratory equipment.